CloneticsTM aortic smooth muscle cells are isolated from human donors that have been diagnosed with diabetes type I or type II disease.
Diseased cells are grown in the same optimized media system as normal human aortic smooth muscle cells. Diabetic AoSMC cultures can be used for experimental applications in diabetic-related cardiovascular pharmaceutical development, vascular pathology, including atherosclerosis. CloneticsTM D-AoSMC diseased human aortic smooth muscle cells and media are convenient and easy to use, allowing the researcher to focus on results. Cryopreserved CloneticsTM AoSMC are shipped in third passage.
Proliferating CloneticsTM AoSMC are shipped in fourth passage. CloneticsTM cells, medium and reagents are quality tested together and guaranteed to give optimum performance as a complete cell system.